XML 76 R47.htm IDEA: XBRL DOCUMENT v3.20.1
RESTATEMENT OF PREVIOUSLY FILED FINANCIAL INFORMATION - Restated Statement of Stockholders' Equity (Details) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Jun. 30, 2019
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Change in Accounting Estimate [Line Items]                                  
Balance $ 517,861,718 $ 508,210,882 $ 467,703,155 $ 462,599,430       $ 356,603,340       $ 290,540,973 $ 462,599,430 $ 462,599,430 $ 462,599,430 $ 356,603,340 $ 290,540,973
Balance (in shares)   508,210,882                              
Common stock issued as consideration in asset acquisition                             28,331,327 11,204,258  
Restricted stock vested                             0 0  
Share-based compensation                             3,082,625 3,870,934 3,685,079
Net income 5,026,692 $ 8,858,000 11,342,597 4,269,260 $ (7,079,308) $ 5,693,628 $ 4,719,806 5,665,634 $ (4,509,935) $ 3,073,760 $ 1,910,763 1,279,281 15,611,857 24,469,857 29,496,551 8,999,760 1,753,869
Balance 523,509,933 517,861,718 $ 508,210,882 467,703,155 462,599,430       356,603,340       $ 508,210,882 517,861,718 523,509,933 462,599,430 356,603,340
Balance (in shares)     508,210,882                   508,210,882        
Common Stock                                  
Change in Accounting Estimate [Line Items]                                  
Balance $ 67,812 $ 67,811 $ 63,230 $ 63,230       $ 54,224       $ 49,113 $ 63,230 $ 63,230 $ 63,230 $ 54,224 $ 49,113
Balance (in shares) 67,811,611 67,811,111 63,229,710 63,229,710       54,224,029       49,113,063 63,229,710 63,229,710 63,229,710 54,224,029 49,113,063
Common stock issued as consideration in asset acquisition                             $ 4,577 $ 2,624  
Common stock issued as consideration in asset acquisition (in shares)                             4,576,951 2,623,948  
Restricted stock vested                             $ 187 $ 65  
Restricted stock vested (in shares)                             187,136 64,620  
Share-based compensation                             $ 0   $ 0
Net income                             0 $ 0 0
Balance $ 67,994 $ 67,812 $ 67,811 $ 63,230 $ 63,230       $ 54,224       $ 67,811 $ 67,812 $ 67,994 $ 63,230 $ 54,224
Balance (in shares) 67,993,797 67,811,611 67,811,111 63,229,710 63,229,710       54,224,029       67,811,111 67,811,611 67,993,797 63,229,710 54,224,029
Additional Paid-in Capital                                  
Change in Accounting Estimate [Line Items]                                  
Balance $ 525,679,942 $ 524,887,107 $ 495,726,558 $ 494,892,093       $ 397,904,769       $ 335,197,845 $ 494,892,093 $ 494,892,093 $ 494,892,093 $ 397,904,769 $ 335,197,845
Common stock issued as consideration in asset acquisition                             28,326,750 11,201,634  
Restricted stock vested                             (187) (65)  
Share-based compensation                             3,082,625 3,870,934 3,685,079
Net income                             0 0 0
Balance 526,301,281 525,679,942 524,887,107 495,726,558 $ 494,892,093       $ 397,904,769       524,887,107 525,679,942 526,301,281 494,892,093 397,904,769
Retained Earnings (Accumulated Deficit)                                  
Change in Accounting Estimate [Line Items]                                  
Balance (7,886,036) (16,744,036) (28,086,633) (32,355,893)       $ (41,355,653)       $ (44,705,985) (32,355,893) (32,355,893) (32,355,893) (41,355,653) (44,705,985)
Common stock issued as consideration in asset acquisition                               0  
Restricted stock vested                             0 0  
Share-based compensation                             0   0
Net income                             29,496,551 8,999,760 1,753,869
Balance (2,859,342) (7,886,036) (16,744,036) (28,086,633) (32,355,893)       $ (41,355,653)       (16,744,036) (7,886,036) (2,859,342) (32,355,893) $ (41,355,653)
As Previously Reported                                  
Change in Accounting Estimate [Line Items]                                  
Balance 526,744,914 516,063,722 474,523,338 462,599,430                 462,599,430 462,599,430 462,599,430    
Common stock issued as consideration in asset acquisition     28,356,396 474,523,338                          
Restricted stock vested   0 0                            
Share-based compensation   792,836 808,734 834,465                          
Net income   9,888,356 12,375,254 11,089,443                 23,464,697 33,353,053      
Balance   526,744,914 516,063,722 474,523,338 462,599,430               516,063,722 526,744,914   462,599,430  
As Previously Reported | Common Stock                                  
Change in Accounting Estimate [Line Items]                                  
Balance $ 67,812 $ 67,811 $ 63,230 $ 63,230                 $ 63,230 $ 63,230 $ 63,230    
Balance (in shares) 67,811,611 67,811,111 63,229,710 63,229,710                 63,229,710 63,229,710 63,229,710    
Common stock issued as consideration in asset acquisition     $ 4,581                            
Common stock issued as consideration in asset acquisition (in shares)     4,581,001                            
Restricted stock vested   $ 1                              
Restricted stock vested (in shares)   500 400                            
Balance   $ 67,812 $ 67,811 $ 63,230 $ 63,230               $ 67,811 $ 67,812   $ 63,230  
Balance (in shares)   67,811,611 67,811,111 63,229,710 63,229,710               67,811,111 67,811,611   63,229,710  
As Previously Reported | Additional Paid-in Capital                                  
Change in Accounting Estimate [Line Items]                                  
Balance $ 525,679,942 $ 524,887,107 $ 495,726,558 $ 494,892,093                 $ 494,892,093 $ 494,892,093 $ 494,892,093    
Common stock issued as consideration in asset acquisition     28,351,815                            
Restricted stock vested   (1)                              
Share-based compensation   792,836 808,734 834,465                          
Balance   525,679,942 524,887,107 495,726,558 $ 494,892,093               524,887,107 525,679,942   $ 494,892,093  
As Previously Reported | Retained Earnings (Accumulated Deficit)                                  
Change in Accounting Estimate [Line Items]                                  
Balance 997,160 (8,891,196) (21,266,450) (32,355,893)                 (32,355,893) (32,355,893) $ (32,355,893)    
Net income   9,888,356 12,375,254 11,089,443                          
Balance   997,160 (8,891,196) (21,266,450) $ (32,355,893)               (8,891,196) 997,160   $ (32,355,893)  
Restatement Adjustment                                  
Change in Accounting Estimate [Line Items]                                  
Balance (8,883,196) (7,852,840) (6,820,183)                            
Net income   (1,030,356) (1,032,657) (6,820,183)                 (7,852,840) (8,883,196)      
Balance   (8,883,196) (7,852,840) (6,820,183)                 (7,852,840) (8,883,196)      
Restatement Adjustment | Retained Earnings (Accumulated Deficit)                                  
Change in Accounting Estimate [Line Items]                                  
Balance $ (8,883,196) (7,852,840) (6,820,183)                            
Balance   $ (8,883,196) $ (7,852,840) $ (6,820,183)                 $ (7,852,840) $ (8,883,196)